Stocksigma LogoStocksigma Logo

Panacea Biotec Reports Share Dematerialization Status for Sep'26

Panacea Biotec Limited submitted its share dematerialization report under Regulation 74(5) of SEBI Regulations for Sep'26

Panacea Biotec Reports Share Dematerialization Status for Sep'26

Panacea Biotec Ltd 路 Others (Uncategorized) 路 07 Oct 2026, 8:52 pm

Panacea Biotec Reports Share Dematerialization Status for Sep'26 Panacea Biotec Limited submitted its share dematerialization report under Regulation 74(5) of SEBI Regulations for Sep'26. A total of 1,000 equity shares were dematerialized during the month under NSDL, while no shares were dematerialized under CDSL. As of 30th Sep'26, the company's total dematerialized equity base reached 6,11,09,526 shares, up by 1,000 shares from 6,11,08,526 shares as of 31st Aug'26. The demat holding comprises 5,25,61,875 shares in NSDL and 85,47,651 shares in CDSL, as confirmed by Registrar and Share Transfer Agent Skyline Financial Services.

Original exchange filing (PDF)

More announcements from Panacea Biotec Ltd

All Panacea Biotec Ltd announcements